Alnylam is headquartered in Cambridge, MA, and engages with users on X (formerly Twitter), LinkedIn, and Instagram. Novartis and Sanofi are partners in commercializing Alnylam products.
2 reports, 1 independent
Updated Aug 5
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alnylam is headquartered in Cambridge, MA, and engages with users on X (formerly Twitter), LinkedIn, and Instagram. Novartis and Sanofi are partners in commercializing Alnylam products.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alnylam Pharmaceuticals
biopharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.
- Alnylam Pharmaceuticals, SEC, Truist Financial, and Nasdaq were involved in insider trading disclosures, analyst ratings, and stock trading on June 6, 2026.
-
Cambridge
city in Middlesex County, Massachusetts, United States of America
-
Novartis
Swiss-American multinational pharmaceutical corporation
-
Sanofi (Japan)
company in Tokyo, Japan
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Business WireAlnylam to Webcast Presentation at Canaccord Genuity 45th Annual Growth Conference CAMBRIDGE, Mass., August 05, 2025--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi t
- Business WireAlnylam to Webcast Conference Call Discussing Second Quarter 2025 Financial Results CAMBRIDGE, Mass., July 17, 2025--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi th